Neurodegenerative Diseases

Original Paper

Role of Interleukin 6 and Alpha-Globulins in Differentiating Alzheimer and Vascular Dementias

Helmy A.A.a · Abdel Naseer M.M.a · El Shafie S.b · Nada M.A.F.a

Author affiliations

aDepartment of Neurology, Faculty of Medicine, Cairo University, Cairo, and bDepartment of Clinical Pathology, Faculty of Medicine, El-Fayoum University, El-Fayoum, Egypt

Keywords: Alpha-1 globulinsAlpha-2 globulinsAlzheimer’s dementiaInflammatory markersInterleukin 6Serum protein electrophoresisVascular dementia

Related Articles for ""
Neurodegenerative Dis 2012;9:81–86
https://doi.org/10.1159/000329568

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: June 08, 2010
Accepted: May 23, 2011
Published online: November 26, 2011
Issue release date: February 2012

Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 6

ISSN: 1660-2854 (Print)
eISSN: 1660-2862 (Online)

For additional information: https://www.karger.com/NDD

Abstract

Background: Inflammatory mechanisms and immune activation have been hypothesized to play a role in the pathogenesis of age-associated diseases, including Alzheimer’s disease. Purpose: The evaluation of inflammatory markers in patients with dementia, and to determine whether these markers can be used to differentiate between vascular dementia (VD) and Alzheimer’s dementia (AD). Patients and Methods: Twenty demented patients (10 AD and 10 VD) and 20 non-demented controls were subjected to clinical evaluation, MRI brain scans and laboratory tests, including interleukin (IL) 6, C-reactive protein and serum protein electrophoresis. Results: The results of this study revealed that serum levels of IL-6 and C-reactive protein were significantly elevated among patients with both types of dementia compared to normal elderly subjects. Although the mean IL-6 level was higher in patients with AD compared to patients with VD, this difference was not significant. The cutoff value at which the serum level of IL-6 gave maximum sensitivity and specificity was 14.25 pg/ml. Moreover, α1- and α2-globulins were able to discriminate between AD and VD (being significantly higher in AD). Conclusion: IL-6 levels could be used to differentiate dementia from normal aging. Moreover, α1- and α2-globulins could differentiate between AD and VD. It can be concluded that inflammation plays an important role in both types of dementia.

© 2011 S. Karger AG, Basel



Related Articles:

References

  1. Mark RJ, Griffiths WS: Interleukin-1, neuroinflammation, and Alzheimer disease. Neurobiol Aging 2001;22:903–908.
    External Resources
  2. McGree EG, McGree PL: The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 1998;33:371–378.
    External Resources
  3. Yaffe K, Lidquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, Launer L, Kuller L, Rubin S, Harris T: Inflammatory markers and cognition in well functioning African-American and White elders. Neurology 2003;61:76–80.
    External Resources
  4. Folstein MF, Folstein SE, McHugh PR: ‘Mini-Mental State’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189–198.
    External Resources
  5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994, pp 138–142.
  6. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
    External Resources
  7. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al: Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.
    External Resources
  8. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L: Cerebral blood flow in dementia. Arch Neurol 1975;32:632–637.
    External Resources
  9. Petrie A, Sabin C: Medical Statistics at a Glance, ed 2. New York, Blackwell, 2005.
  10. Ott A, Breteler MMB, Harskamb F, Claus JJ, van der Cammen TJM, Grobbee DE, Hofman A: Prevalence of Alzheimer disease and vascular dementia: association with education. The Rotterdam Study. BMJ 1995;310:970–973.
    External Resources
  11. Blasko I, Grubeck-Loebenstein B: Role of immune system in the pathogenesis, prevention and treatment of Alzheimer disease. Drug Aging 2003;20:101–113.
    External Resources
  12. Hebert R, Lindsay T, Verreault R, Rockwood K, Hill G, Dubois MF: Vascular dementia: incidence and risk factors in the Canadian Study of Health and Aging. Stroke 2000;31:1487–1493.
    External Resources
  13. Desmond DW, Moroney JJ, Paik MC, Sano M, Mohr JP, Aboumatar S, et al: Frequency and clinical determinants of dementia after ischemic stroke. Neurology 2000;54:1124–1128.
    External Resources
  14. Goldstein FC, Ashley AV, Freedman L, Penix L, Lah LL, Hanfelt J, Levey AI: Hypertension and cognitive performance in African Americans with Alzheimer disease. Neurology 2005;64:899–901.
    External Resources
  15. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, et al: Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002;346:476–483.
    External Resources
  16. Aliev G, Smith MA, Seyidov D, Neal ML, Lamb BT, Nunomura A, et al: The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer’s disease. Brain Pathol 2003;12:21–35.
    External Resources
  17. Hansson GK: Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005;352:1685–1695.
    External Resources
  18. Peila R, Launer LJ: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu Asia Aging Study. Diabetes 2006;51:1256–1262.
    External Resources
  19. De Luigi A, Fragiacomo C, Lucca U, Quadri P, Tettamanti M, Grazia De Simoni M: Inflammatory markers in Alzheimer disease and multi-infarct dementia. Mech Aging Dev 2001;122:1985–1995.
    External Resources
  20. Sun Y, Minthon L, Wallmark A, Warkentin S, Blennow K, Janciauskiene S: Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer disease. Dement Geriatr Cogn Disord 2003;16:136–144.
    External Resources
  21. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R: Plasma homocysteine levels and risk of Alzheimer disease. Neurology 2004;62:1972–1976.
    External Resources
  22. Ravalgia G, Forti P, Maioli F, Chiappellib M, Montesia F, Tuminib E, et al: Blood inflammatory markers and risk of dementia. Neurobiol Aging 2006;107:6632–6643.
  23. Stewart R, Masaki K, Xue Q-L, Peila R, Petrovitch H, White LR, Launer LJ: A 32-years prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 2005;62:55–60.
    External Resources
  24. Visser M, Pahor M, Taafe DR, Goodpaster BH, Simonsick EM, Newman AB, et al: Relationship of interleukin-6 and tumor necrosis factor alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol Med Sci 2002;57:M326–M332.
    External Resources
  25. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al: Inflammatory markers and onset of cerebrovascular events: result from the Health ABC Study. Circulation 2003;108:2317–2322.
    External Resources
  26. Cacquevel M, Lebeurrier N, Cheenne S, Vivien D: Cytokines in neuroinflammation and Alzheimer disease. Current Drug Targets 2004;5:529–534.
    External Resources
  27. Schmidt R, Schmidt H, Curb JD, et al: Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002;52:168–174.
    External Resources
  28. Ravalgia G, Forti P, Maioli F, et al: Blood inflammatory markers and risk of dementia. Neurobiol Aging 2006;107:6632–6643.
  29. Vesna J, Robert S, Emma D, et al: Markers of inflammation and cognitive decline in an African-Caribbean population. Int J Geriatr Psychiatry 2007;22:966–973.
    External Resources
  30. Zuliana G, Guerra G, Ranzini M, Rossi L, Munari MR, Zurlo A, et al: High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia. Int J Geriatr Psychiatry 2007;22:305–311.
    External Resources
  31. Morely JE, Baumgartner RN: Cytokine-related aging process. J Gerontol A Biol Sci Med Sci 2004;59:M924–M929.
    External Resources
  32. Ershler WB, Keller ET: Age-associated increased interleukin-6 gene expression, late life diseases, and frailty. Ann Rev Med 2000;51:245–270.
    External Resources
  33. Elwan O, Madkour O, Elwan F, Mostafa M, Helmy A, Abdel-Naseer M, et al: Brain aging in normal Egyptians: cognition, education, personality, genetic and immunological study. J Neurol Sci 2003;211:15–22.
    External Resources
  34. Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, Byers HL, et al: Proteome-based plasma biomarker for Alzheimer disease. Brain 2006;129:3042–3050.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: June 08, 2010
Accepted: May 23, 2011
Published online: November 26, 2011
Issue release date: February 2012

Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 6

ISSN: 1660-2854 (Print)
eISSN: 1660-2862 (Online)

For additional information: https://www.karger.com/NDD

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2012, Vol.9, No. 2

February 2012

Article

Recommend This
TOP